Erin K. Brenner - Dec 3, 2021 Form 4 Insider Report for Pear Therapeutics, Inc. (PEARQ)

Role
Chief Product Dev. Officer
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
Stock symbol
PEARQ
Transactions as of
Dec 3, 2021
Transactions value $
$0
Form type
4
Date filed
12/7/2021, 04:24 PM
Next filing
Feb 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEARQ Stock Option (Right to Buy) Award +120K 120K Dec 3, 2021 Common Stock 120K $1.00 Direct F1, F2
transaction PEARQ Stock Option (Right to Buy) Award +44.2K 44.2K Dec 3, 2021 Common Stock 44.2K $1.08 Direct F3, F4
transaction PEARQ Stock Option (Right to Buy) Award +101K 101K Dec 3, 2021 Common Stock 101K $1.09 Direct F5, F6
transaction PEARQ Stock Option (Right to Buy) Award +54.9K 54.9K Dec 3, 2021 Common Stock 54.9K $1.12 Direct F7, F8
transaction PEARQ Stock Option (Right to Buy) Award +21.1K 21.1K Dec 3, 2021 Common Stock 21.1K $1.12 Direct F9, F10
transaction PEARQ Stock Option (Right to Buy) Award +58.9K 58.9K Dec 3, 2021 Common Stock 58.9K $1.29 Direct F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vested or shall vest on July 16, 2019 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F2 Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for an option to acquire 81,659 shares of common stock of Private Pear for $1.46 per share.
F3 25% of the shares underlying the option vested or shall vest on March 14, 2020 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F4 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 30,000 shares of common stock of Private Pear for $1.58 per share.
F5 25% of the shares underlying the option vested or shall vest on March 24, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F6 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 68,341 shares of common stock of Private Pear for $1.60 per share.
F7 25% of the shares underlying the option vested or shall vest on June 23, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F8 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 37,304 shares of common stock of Private Pear for $1.64 per share.
F9 25% of the shares underlying this option vested or shall vest on June 23, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F10 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 14,355 shares of common stock of Private Pear for $1.64 per share.
F11 25% of the shares underlying the option vested or shall vest on January 26, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F12 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 40,000 shares of common stock of Private Pear for $1.89 per share.